Waxman Questions Why Drug Companies Continue to Market Cold Medicines to Infants |
Today Chairman Waxman wrote to the Consumer Healthcare Products Association, the trade association that represents manufacturers of over-the-counter drugs. In his letter, Chairman Waxman asks the CHPA why its member companies continue to market over-the-counter cough and cold medicines for use in infants even after the CHPA has said to FDA that these products should not be sold for use in children under two. Documents and Links |
Committee On Oversight and Government Reform
U.S. House of Representatives | 2157 Rayburn House Office Building | Washington, D.C. 20515 | (202) 225-5051